Company: SMNR
Filing Date: 2025-08-12
Form Type: S-4/A
Source: 0001193125-25-178821
Chunk: 334

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-12
Form: S-4/A
Chunk 334
---
asdaqGM:AXSM)          |     |               |  84.85 |     |             |    48 |     |           | — |     |              |   4,073 |

Notes:

| (1) | Values in thousands of US dollars, except stock price per share and shares outstanding. |

| (2) | Corresponding values continued in table below. |

| (3) | Source: S&P Capital IQ. |

Comparable Company Information (Continued)

| Comparable Company Names                           |     | Total    
 Interest 
 Bearing  
 Debt($)  |        |     | Total      
 Invested   
 Capital($) |         |     | Less: Cash($) |        |     | Total    
 Minority 
 Interest |   |     | Enterprise 
 Value($)   |         |
| Amgen Inc. (NasdaqGS:AMGN)                         |     |          | 65,423 |     |            | 239,222 |     |               | 10,944 |     |          | — |     |            | 228,278 |
| Pacira BioSciences, Inc. (NasdaqGS:PCRX)           |     |          |    586 |     |            |   1,158 |     |               |    153 |     |          | — |     |            |   1,005 |
| CVS Health Corporation (NYSE:CVS)                  |     |          | 79,385 |     |            | 149,605 |     |               |  8,196 |     |          | — |     |            | 141,409 |
| Pfizer Inc. (NYSE:PFE)                             |     |          | 75,332 |     |            | 238,816 |     |               |  2,853 |     |          | — |     |            | 235,963 |
| Eli Lilly and Company (NYSE:LLY)                   |     |          | 26,467 |     |            | 844,099 |     |               |  2,819 |     |          | — |     |            | 841,280 |
| Viatris Inc. (NasdaqGS:VTRS)                       |     |          | 18,371 |     |            |  32,180 |     |               |    992 |     |          | — |     |            |  31,188 |
| Teva Pharmaceutical Industries